Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Encore Vision Inc.
Description1.5% lipoic acid choline ester, which breaks down into lipoic acid and choline
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationPresbyopia
Indication DetailsTreat presbyopia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today